跳至主要内容
临床试验/NCT04751565
NCT04751565已完成不适用

Analysis of the Treatment of Non-surgical Peri-implant Mucositis Treatment in Patients With Tissue-level (TL) and Bone-level (BL) Implants

University of Messina1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2021年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
1
主要终点
Bleeding on Probing (BOP) changes

研究概览

简要总结

This study is designed to compare the resolution of inflammation of naturally-occurring peri-implant mucositis (PM) at tissue-level (TL) and bone-level (BL) implants after non-surgical mechanical debridement.

详细描述

Group A: Peri-implant mucositis (PM) at tissue-level (TL) implants after non-surgical mechanical debridement.

Group B: Peri-implant mucositis (PM) bone-level (BL) implants after non-surgical mechanical debridement.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male and female aged > 18 years
  • •TL and BL titanium implants with smooth necks supporting cemented or screw-retained single-unit crowns diagnosed with PM (Berglundh, et al.,2018)
  • •Implants placed in both arches
  • •Patients with gingivitis or treated periodontitis (i.e., absence of residual PD > 5 mm)
  • •Presence of at least 2 mm of keratinized mucosa at implant sites.

排除标准

  • •presence of medical conditions contraindicating treatment of peri-implant mucositis,
  • •regular use of anti-inflammatory drugs or antibiotics within 3 months prior to study enrollment
  • •Presence of systemic diseases
  • •Pregnant and lactating females
  • •Smokers > 10 cigarettes/day
  • •Use of inflammatory drugs or antibiotics within 3 months prior to study recruitment
  • •Implants with modified (i.e. micro-rough) necks
  • •Interproximal open contacts between implant restoration and adjacent teeth
  • •Peri-implantitis (Renvert, et al., 2018)

研究组 & 干预措施

Tissue level implant Group

Experimental

Evaluation of healing of peri-implant mucositis after non-surgical supra and subgingival debridement in patients with tissue level implant

Primary outcome

The primary outcome will be based on probing depth (PD)

干预措施: Bleeding on Probing change reduction following peri-implant mucositis non surgical therapy (Other)

Bone level implant Group

Experimental

Evaluation of healing of peri-implant mucositis after non-surgical supra and subgingival debridement in patients with bone level implant

Primary outcome

The primary outcome will be the change in Bleeding on Probing (BOP) (Lang, Joss, Orsanic, Gusberti, Siegrist, 1986).

干预措施: Bleeding on Probing change reduction following peri-implant mucositis non surgical therapy (Other)

结局指标

主要结局

Bleeding on Probing (BOP) changes

时间窗: Baseline (T0), 3-months (T1) and at 6-months (T2)

Changes over time in BOP changes (percentage)

次要结局

  • Full mouth plaque score (FMPS) changes(Baseline (T0), 3-months (T1) and at 6-months (T2))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gaetano Isola, DDS, PhD

Researcher

University of Messina

研究点 (1)

Loading locations...

相似试验

Non Surgical Peri-implant Mucositis Treatment in... | 临床试验